Hosted on MSN42m
Biogen Rises On FDA Nod for Alzheimer's Drug Dosing Regimen, But Sage Deal Fallout Irks RetailBiogen Inc. shares climbed 1.7% on Monday afternoon, reaching a nearly two-week high, as positive regulatory news countered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback